. To disable them, configure your browser properly. If you keep using this website, you are accepting those.
DEPARTMENT OF INFECTION & IMMUNITY
Platforms & Technologies
NextImmune - PhD training program
DEPARTMENT OF ONCOLOGY
Scientific Advisory Board
Canbio - PhD training program
DEPARTMENT OF POPULATION HEALTH
Scientific Advisory Board
Methodology and Statistics
Business Development Office
Quality, Health, Safety and Environment
Mission & Vision
Organisation / management
Working with LIH
Crédit d’impôt recherche
LIH and Tolerogenics collaborate on immune tolerance-promoting therapies
markus ollert, tolerogenics, immune tolerance, autoimmune disease, allergic disease
The Luxembourg-based biotech start-up Tolerogenics is developing novel immunotherapies based on the induction of immune tolerance.
September 17, 2019
Innovative approach that makes “cold” tumours “hot”
sprint bioscience, bassam janji, vps34, autophagy, immunotherapy
A recent news article in Nature Reviews Drug Discovery highlights innovative approaches aiming to improve the efficiency of cancer immunotherapy.
September 09, 2019
Luxembourg’s hepatitis C screening and care in drug users selected as example of best practice in Europe
world hepatitis day, carole devaux, hepatitis c, drug users
The World Hepatitis Day on 28th July is an opportunity to raise awareness on the disease and on research conducted in this area.
July 25, 2019
Luxembourg Parkinson’s Study funded with an additional six million euros
parkinson, ncer-pd, patient stratification, patient empowerment, rejko krüger
The Luxembourg National Research Fund has committed an additional six million euros to the National Centre for Excellence in Research on Parkinson’s Disease.
July 23, 2019
Bringing biomedical research closer to the patient: appointments to strategic positions
rejko krüger, simone niclou, guy berchem, translational medicine
LIH is currently refining its research strategy to focus more on translational research, placing patients and the population at the centre of its activities.
July 11, 2019
Top Japanese research consolidates ties with Luxembourg
riken-ims, lcsb, ulf nehrbass, outpost labs
Representatives of the Japanese RIKEN Institute, the University of Luxembourg and LIH have signed a Memorandum of Understanding on 9th July 2019.
July 10, 2019
Biomarker identification for a better care of diabetic cardiomyopathy
diabetic cardiomyopathy, yvan devaux, biomarker identification, cardiateam
LIH is a partner in CARDIATEAM, a large translational research project funded by the Innovative Medicines Initiative IMI2.
July 09, 2019
LIH gut microbiome research as the cover story of a leading news magazine Der Spiegel
microbiome, mahesh desai, der spiegel, dietary fibre, markus ollert
Der Spiegel, published its latest cover story focussed on human gut microbiome research.
July 05, 2019
The Cancer Foundation supports a research project on a novel therapeutic protein for Glioblastoma
virginie neirinckx, simone niclou, glioblastoma, receptor tyrosine kinase, fondation cancer
The Cancer Foundation (Fondation Cancer) funds a research project on brain cancer at the NorLux Neuro-Oncology Laboratory in LIH’s Department of Oncology.
July 02, 2019
LIH allergology researchers distinguished at Europe's largest allergy conference
markus ollert, eaaci, allergology, christiane hilger
LIH was well represented at this year’s annual EAACI Congress to communicate on the successful projets in allergy research conducted in Luxembourg.
July 01, 2019
NextImmune PhD retreat 2019: insights into hot immunology topics
nextimmune, immunology, phd candidates, markus ollert, pride
The second scientific retreat of the Doctoral Training Unit (DTU) NextImmune took place at the Alvisse Parc Hotel in Luxembourg from 7th to 9th May 2019.
June 26, 2019
Philanthropy supporting cancer research
cancer research, philanthropy, oncolytic virus, virotherapy, antonio marchini
The Laboratory of Oncolytic Virus Immuno-Therapeutics (LOVIT) at LIH’s Department of Oncology received a generous private donation.
June 20, 2019
Affiliated Professorships with University of Luxembourg
ulf nehrbass, laetitia huiart, university of luxembourg, park-qc, e-health
Prof Ulf Nehrbass, CEO of LIH, and Prof Laetitia Huiart, Director of the Department of Population Health, have been appointed as affiliated professors.
June 06, 2019
Restoring the anti-tumour immune response - a new research project funded by the Cancer Foundation
fondation cancer, actin response, breast cancer, clément thomas
Luxembourg’s Cancer Foundation supports a new research project from LIH that aims to evaluate the effectiveness of targeting a new mechanism in cancer cells.
June 03, 2019
Cancer cells are quick-change artists adapting to their environment
Until now, researchers have assumed that the growth of solid tumours originates from cancer stem cells characterised by specific surface markers.
May 29, 2019
Merging business intelligence with biology
business intelligence, cytometry, antonio cosma, national cytometry platform
In November 2018, Dr Antonio Cosma joined LIH as the new Head of the National Cytometry Platform.
May 23, 2019
Successful EDEG conference: new perspectives for diabetes prevention and patient care
edeg, diabetes, gloria aguayo, prevention, treatment
From 11th to 14th May, diabetes research and care was put at the forefront in Luxembourg.
May 22, 2019
New pilot study: a step towards personalised cancer therapy?
functional profiling, ulf nehrbass, cancer therapy, glioblastoma, nano-spheroids
Cancer cells exhibit great genetic diversity, even within tumours of a patient.
May 16, 2019
Global Burden Study: obesity rising faster in rural areas than in cities
obesity, public health, bmi, alkerwi
LIH contributed to a worldwide public health study published in Nature in May 2019.
May 15, 2019
Does protein intake improve the bioavailability of carotenoids?
carotenoid, nutrition research, torsten bohn, mohammed iddir
LIH launches CAROPROT, a new study in nutrition research with healthy volunteers.
May 13, 2019